Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial.

Auteurs

Steenackers K, Hanning N, Bruckers L, Desombere I, Marchant A, Ariën KK, Georges D, Soentjens P, D'Onofrio V, Hites M, Berens-Riha N, De Coster I, Damme PV

  • Date de publication

    Juli 2024

  • Type

    Article

  • Tijdschrift

    Vaccine

  • Naam van de onderzoeker

    Hites Maya

  • Hôpital

    Hôpital Erasme

  • Dienst

    Médecine Interne

  • PMID

    39019657

  • DOI

    10.1016/j.vaccine.2024.07.018